SCHEMBL24449893

SCHEMBL24449893

COCCc1nn(Cc2ccc(OC)cc2)cc1C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ AADAT Q8N5Z0 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HDAC1 Q13547 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KLKB1 P03952 3/20 0.38
▸ SNCA P37840 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CALM1 P0DP23 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ CMA1 P23946 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25947865 0.88 RAB9A (0.41) MEN1NPC1RAB9AKMT2AHDAC1
SCHEMBL24448756 0.83 MEN1 (0.45) HSP90AA1HSP90AB1AADATMEN1NPC1
SCHEMBL24448755 0.80 AADAT (0.40) HSP90AA1HSP90AB1AADATMEN1NPC1
SCHEMBL26800277 0.79 HSP90AA1 (0.38) HSP90AA1HSP90AB1MEN1NPC1RAB9A
SCHEMBL370625 0.71 MEN1 (0.44) HSP90AA1HSP90AB1AADATMEN1NPC1
SCHEMBL24449775 0.70 SMN1; SMN2 (0.37) HSP90AA1MEN1NPC1RAB9AKMT2A
SCHEMBL370508 0.70 KMT2A (0.53) MEN1NPC1RAB9AKMT2AKLKB1
SCHEMBL369027 0.70 KLKB1 (0.51) KMT2AKLKB1CMA1
SCHEMBL4552450 0.70 MEN1 (0.45) HSP90AA1HSP90AB1AADATMEN1NPC1
SCHEMBL369754 0.69 KLKB1 (0.52) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 — — US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 — — US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A HSP90AA1 1332/4885HSP90AB1 948/4885AADAT 2570/4885
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A HSP90AA1 1332/4885HSP90AB1 948/4885AADAT 2570/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A HSP90AA1 1332/4885HSP90AB1 948/4885AADAT 2570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback